iScienceGenetic & Genomic MedicinePeer-reviewed journal article
Fine resolution clustering of TP53 variants into functional classes predicts cancer risks and spectra among germline variant carriers
Emilie MontellieriD, Nathanaël LemonnieriD, Judith PenkertiD, Claire FreyçoniD, Sandrine BlanchetiD, Amina AmadouiD, Florent ChuffartiD, Nicholas William FischeriD, Maria Isabel AchatziD, Arnold J. LevineiD, Catherine GoudieiD, David M. MalkiniD, Gaëlle BougeardiD, Christian Peter KratziD, Pierre L. HainautiD
Abstract
Li-Fraumeni syndrome (LFS) is a heterogeneous predisposition to a broad spectrum of cancers caused by pathogenic TP53 germline variants. We have used a clustering approach to assign missense variants to functional classes with distinct quantitative and qualitative features based on transcriptional activity in yeast assays. Genotype-phenotype correlations were analyzed using the germline TP53 mutation database (n= 3,446) and validated in three LFS clinical cohorts (n= 821). Carriers of class A variants recapitulated all traits of fully penetrant LFS (median age at first diagnosis = 28 years). Class B carriers showed a less penetrant form (median = 33 years, p < 0.05) dominated by adrenocortical and breast cancers. Class C or D carriers had attenuated phenotypes (median = 41 years, p < 0.001) with typical LFS cancers in C and mostly non-LFS cancers in D. This new classification provides insight into structural/functional features causing pathogenicity.
- organism: human
- assay: DNA methylation
- assay: whole-exome sequencing
- research focus: cell type annotation
- approach: statistical model
- Citations
- 30
- FWCI
- 5.11
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Shared inheritance reveals landscape of somatic and germline cancer risk in TP53
Hamish A J MacGregor, Jamie R. Blundell, Douglas F. Easton·The American Journal of Human GeneticsPeer-reviewed·Aug 17, 2026
- Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants
Cristina Fortuño, Kristy Lee, … the ClinGen TP53 Variant Curation Expert Panel·Human MutationPeer-reviewed·Dec 10, 2020
- Neoantigenic properties of TP53 variants modify cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, … Pierre L. Hainaut·EBioMedicinePeer-reviewed·Dec 9, 2025
- Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53
Cristina Fortuño, Marcy E. Richardson, … Amanda B. Spurdle·Human Genetics and Genomics AdvancesPeer-reviewed·Jul 21, 2025
- Risk of differential cancer types over age in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts
Seung Jun Shin, Elissa B. Dodd-Eaton, … Wenyi Wang·bioRxiv·Mar 5, 2019
- Risk of multiple primary cancer diagnosis over age in families of Li-Fraumeni syndrome: a single institution perspective
Seung Jun Shin, Elissa B. Dodd-Eaton, … Wenyi Wang·Cancer ResearchPeer-reviewed·Nov 12, 2019